The roles of a process development group in biopharmaceutical process startup

Cytotechnology

Volumn 38, Issue 1-3, 2002, Pages 63-76

  Goochee, Charles F ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Biopharmaceutical; Manufacturing; Plant startup; Process development; Process startup; Process transfer

Indexed keywords

EID: 0036425992     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021149914161     Document Type: Conference Paper

References (9)

1. Andersen DC, Swartz J, Ryll T, Lin N & Snedecor B (2001) Metabolic oscillations in an E. Coli fermentation. Biotechnol Bioeng 75: 212-218.
2. Birch JR, Boraston R & Wood L (1985) Bulk production of monoclonal antibodies in fermenters. Trends Biotechnol 3: 162-166.
3. Gerson DF, Himes V, Hopfer R, Khandke L, Kohn F, Komotar A, Krumm P, Machulski J, Weisser A & Sciotto-Brown S (1998) Transfer of processes from development to manufacturing. Drug Inform J 32: 19-26.
4. Goochee CF & Monica T (1990) Environmental effects on protein glycosylation, Bio/Technology 8: 421-427.
5. Hu, W-S & Aunins JG (1997) Large-scale mammalian cell culture. Currt Opin Biotechnol 8: 148-153.
6. Pisano GP (1997) The Development Factory. Harvard Business School Press, Boston.
7. Swartz JR (1994), U.S. Patent 5,342,763. Method for Producing Polypeptide via Bacterial Fermentation, Issued 8/30/94.
8. Swartz JR (1996), U.S. Patent 5,487,980. Method of Determining Propensity for Dissolved Oxygen Instability, Issued 1/30/96.
9. Swartz JR (1997), U.S. Patent 5,633,165. Fermentor with Vertical Shaft, Issued May 27, 1997.